GP

Graham Parry

BU Bioverativ Usa: 8 patents #1 of 7Top 15%
TT True North Therapeutics: 8 patents #1 of 4Top 25%
GE Genzyme: 4 patents #178 of 891Top 20%
AT AT&T: 1 patents #10,626 of 18,772Top 60%
IP Ipierian: 1 patents #4 of 8Top 50%
📍 South San Francisco, CA: #82 of 1,066 inventorsTop 8%
🗺 California: #23,010 of 386,348 inventorsTop 6%
Overall (All Time): #166,883 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
12391750 Anti-C1S antibodies and methods of use thereof Sandip Panicker, Nancy E. Stagliano 2025-08-19
12240917 Anti-complement C1s antibodies and uses thereof Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2025-03-04
12215169 Anti-complement C1s antibodies and uses thereof Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2025-02-04
11999780 Humanized anti-complement factor Bb antibodies and uses thereof Stephen Moore, Michael Storek, Nina C. Leksa 2024-06-04
11851482 Anti-complement factor Bb antibodies and uses thereof Sandip Panicker, Karen Sue Christopherson, Tony SangYoung Byun 2023-12-26
11246926 Polynucleotides encoding anti-C1s antibodies Sandip Panicker 2022-02-15
11242382 Humanized anti-complement factor Bb antibodies Stephen Moore, Michael Storek, Nina C. Leksa 2022-02-08
11192944 Methods of inducing complement activity Sandip Panicker, Stephen Moore, Pavel A. Nikitin, Tony SangYoung Byun 2021-12-07
10934347 Anti-complement factor BB antibodies and uses thereof Sandip Panicker, Karen Sue Christopherson, Tony SangYoung Byun 2021-03-02
10729767 Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage Sandip Panicker 2020-08-04
10457745 Anti-complement C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2019-10-29
10450382 Anti-complement C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2019-10-22
10400018 Tau peptides, anti-tau antibodies, and methods of use thereof Irene Griswold-Prenner, Tony SangYoung Byun 2019-09-03
9562106 Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2017-02-07
9562092 Methods of inhibiting complement C4 activation with anti-complement C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2017-02-07
9512233 Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2016-12-06
9206259 Methods of inhibiting complement C4 activation with anti-complement C1S antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2015-12-08
9074004 Methods of inhibiting activation of complement component C4 with anti-C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2015-07-07
9074003 Methods of inhibiting activation of complement component C4 with anti-C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2015-07-07
8945562 Anti-complement C1s antibodies Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2015-02-03
8877197 Anti-complement C1s Peter Van Vlasselaer, Nancy E. Stagliano, Sandip Panicker 2014-11-04
8105602 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof Andrew P. Mazar 2012-01-31
8101726 Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy Andrew P. Mazar 2012-01-24
7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof Robert J. Ternansky, Stephanie Hopkins, Won Hyung Yoon, Amy Allan, Patricia Gladstone +4 more 2009-04-14